Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence
Crossref DOI link: https://doi.org/10.1057/s42214-020-00068-4
Published Online: 2020-09-03
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Urias, Eduardo
Ramani, Shyama V.
Text and Data Mining valid from 2020-09-03
Version of Record valid from 2020-09-03
Article History
Received: 10 January 2019
Revised: 3 July 2020
Accepted: 28 July 2020
First Online: 3 September 2020
Free to read: This content has been made available to all.